Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine and rifaximin trial (EudraCT 2005-001268-30)
2005-001268-30Phase 3Active
- Sponsor
- SOFAR
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Salcrozine and rifaximin, sponsored by SOFAR. Started Feb 2007; status: active.
02
Drugs
Salcrozinerifaximin
Beyond the preview
Go deeper on 2005-001268-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001268-30.